Chinese Startup Expands Methane Rocket Program with Latest Launch

China’s private aerospace company LandSpace Technology successfully launched six satellites into orbit on Saturday using its methane-powered Zhuque-2E Y2 carrier rocket. The launch, conducted at the Jiuquan Satellite Launch Center, marks the fifth flight in the Zhuque-2 series.

LandSpace became the first company worldwide to launch a methane-liquid oxygen rocket in July 2023, ahead of US competitors like SpaceX and Blue Origin. Methane has gained interest as a cleaner, safer, and cost-effective alternative to traditional rocket fuels, making it an ideal choice for reusable spacecraft.

The company has expanded its rocket payload capacity to meet growing commercial demand, particularly in satellite deployment efforts aimed at rivaling Musk’s Starlink constellation. While LandSpace’s initial methane-powered launch did not carry satellites, its second mission in December 2023 successfully placed three into orbit.

Saturday’s launch carried six satellites, primarily developed by Chinese firm Spacety, including a radar satellite, two multispectral satellites, and three research satellites. These satellites will support deep-space exploration, environmental monitoring, mineral detection, and urban development.

Reusable rockets have proven to significantly reduce space launch costs. LandSpace’s CEO, Zhang Changwu, confirmed that the company is developing reusable models, with test flights expected in late 2025. The latest Zhuque-2 variant incorporates new technology to enhance propulsion efficiency, marking an advancement in China's commercial space sector.

Since China opened its space industry to private investment in 2014, LandSpace has emerged as a major player, securing funding from venture capital firms, real estate investors, and state-backed initiatives. The company raised 900 million yuan ($120 million) in December 2024 and had previously secured 1.2 billion yuan ($170 million) in 2020 to support its aerospace advancements.


Comment As:

Comment (0)